Proteogenomics reveals markers of chemotherapy resistance and outcome in triple negative breast cancer
Broad Institute
AUGUST 24, 2022
Louis have identified biological markers in triple negative breast cancer (TNBC) that are associated with resistance to chemotherapy treatment. It is imperative that we develop approaches to predict response so that only effective treatments are given. 33, was associated with resistance to chemotherapy treatment.
Let's personalize your content